| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 12/30/2003 | CA2121358C Thymidine phosphorylase for use in the modulation of cellular proliferation or chemotaxis |
| 12/25/2003 | WO2003105846A1 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections |
| 12/25/2003 | US20030237101 Stem cell factor; modulation of gene expression |
| 12/25/2003 | US20030236411 Antisecretory agents for treating a peptic ulcer |
| 12/25/2003 | US20030236405 7-hetero-bicyclo[2.2.1]-heptanes |
| 12/25/2003 | US20030236389 Proteins, polynucleotides encoding them and methods of using the same |
| 12/25/2003 | US20030236309 Novel formate salt of O-desmethyl-venlafaxine |
| 12/25/2003 | US20030236303 Therapeutic compositions and methods of use |
| 12/25/2003 | US20030236281 Quinoline derivatives(2) |
| 12/25/2003 | US20030236280 Aminotetralin-derived urea modulators of vanilloid VR1 receptor |
| 12/25/2003 | US20030236263 Chemical compounds |
| 12/25/2003 | US20030236260 Antiarthritic agents; autoimmune diseases; anticholesterol agents; cardiovascular disorders; antiinflammatory agents |
| 12/25/2003 | US20030236258 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 12/25/2003 | US20030236250 Antidepressants, anxiolytic agents, analgesics, antiinflammatory agents, reduce concentration of tachykinins |
| 12/25/2003 | US20030236230 Comprises 4-substituted piperidine ring linked to a substituted or unsubstituted hydrocarbyl ring; for controlling weight gain in a human or higher mammal |
| 12/25/2003 | US20030236217 Administering ADP-ribose |
| 12/25/2003 | US20030236216 For the treatment of diseases mediated by the Hepatitis C Virus |
| 12/25/2003 | US20030236213 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders |
| 12/25/2003 | US20030236212 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders |
| 12/25/2003 | US20030236183 Comprises 5-HT4 receptor antagonists/agonists; for treatment of gastrointestinal disorders; veterinary medicine |
| 12/25/2003 | US20030236182 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 12/25/2003 | US20030235900 Anticancer agents |
| 12/25/2003 | US20030235820 Detecting and identifying tumor related transcripts associated with cancer; screening and monitoring antiproliferative agents |
| 12/25/2003 | US20030235628 Mixtures of proton pump inhibitor such as lansoprazole and water soluble and insoluble bases, used for prophylaxis of gastrointestinal disorders; neutralization gastric juices |
| 12/25/2003 | US20030235609 Use of cholinesterase antagonists to treat insulin resistance |
| 12/25/2003 | US20030235591 Comprises hepatitis B surface antigens |
| 12/25/2003 | US20030235588 Thioredoxin (TRX); administering histone deacetylase inhibitors such as trichostatin A; for treating inflammation |
| 12/25/2003 | US20030235585 Methods of treating disorders in which TFN alpha activity is detrimental via biweekly, subcutaneous administration of human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor alpha |
| 12/25/2003 | US20030235563 Placental derived stem cells and uses thereof |
| 12/24/2003 | WO2003106670A1 Recombinant triacylglycerol lipase of arabidopsis thaliana, nucleotide sequences coding for same or corresponding to antisense sequences and uses thereof |
| 12/24/2003 | WO2003106660A2 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 12/24/2003 | WO2003106629A2 Treating vitamin d responsive diseases |
| 12/24/2003 | WO2003106507A1 Per (3,6-anhydro) cyclodextrin derivatives, their preparation and use thereof for separating ions, in particular chromium and manganese anions |
| 12/24/2003 | WO2003106462A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 12/24/2003 | WO2003106455A1 Azole methylidene cyanide derivatives and their use as protein kinase modulators |
| 12/24/2003 | WO2003106444A1 N,n-disubstituted diazocycloalkanes useful for the treatment of cns disorders due to serotonergic dysfunction |
| 12/24/2003 | WO2003106441A1 Pharmaceutical salts of reboxetine |
| 12/24/2003 | WO2003106431A2 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same |
| 12/24/2003 | WO2003106429A1 Prodrug and process for producing the same |
| 12/24/2003 | WO2003106425A2 Phenyl- and pyridyl-diazaheterocycles having a tnf-modulating activity |
| 12/24/2003 | WO2003106423A1 Cyclic amine and medicinal composition containing the same |
| 12/24/2003 | WO2003106420A1 2,5-disubstituted 3-mercaptopentanoic acid |
| 12/24/2003 | WO2003106418A1 Indole, indazole, and benzazole derivative |
| 12/24/2003 | WO2003106403A1 Carboxamides derivatives |
| 12/24/2003 | WO2003106381A2 Human adam-10 inhibitors |
| 12/24/2003 | WO2003105909A1 Medicine for prevention of and/or treatment for liver inshemiareperfusion injury and protective agent for transplant liver |
| 12/24/2003 | WO2003105893A2 Probiotic therapies |
| 12/24/2003 | WO2003105885A1 Novel method of screening |
| 12/24/2003 | WO2003105872A1 Anti-spasmodic comprising xenon |
| 12/24/2003 | WO2003105870A1 Verotoxin production inhibitor |
| 12/24/2003 | WO2003105845A1 Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers |
| 12/24/2003 | WO2003105838A2 Metabolite |
| 12/24/2003 | WO2003105833A1 Formulation of nefopam and its use in the treatment of pain |
| 12/24/2003 | WO2003105832A1 Use of nefopam for the treatment of nausea or emesis |
| 12/24/2003 | WO2003105819A1 Quinone-type remedy for liver disease |
| 12/24/2003 | WO2003105818A1 Quinone-based remedies for liver diseases |
| 12/24/2003 | WO2003105815A1 Combination of pde-v inhibitors and nk1 antagonists for the treatment of depression |
| 12/24/2003 | WO2003105811A2 Controlled release compositions and methods for using same |
| 12/24/2003 | WO2003105800A2 Film-shaped mucoadhesive administration form for administering cannabis active ingredients |
| 12/24/2003 | WO2003105781A2 Ophthalmic compositions for treating ocular hypertension |
| 12/24/2003 | WO2003105776A2 ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE |
| 12/24/2003 | WO2003105771A2 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists |
| 12/24/2003 | WO2003105596A1 Mammalian animal compositon |
| 12/24/2003 | WO2003091274A3 Use of alpha-s2 casein precursor-derived peptided |
| 12/24/2003 | WO2003091232A3 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 12/24/2003 | WO2003090662A3 Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease |
| 12/24/2003 | WO2003086396A9 Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative |
| 12/24/2003 | WO2003084940B1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors |
| 12/24/2003 | WO2003082807A3 Amino acids with affinity for the alpha-2-delta-protein |
| 12/24/2003 | WO2003072558A3 Arylsulfone derivatives |
| 12/24/2003 | WO2003070914A3 RNA INTERFERENCE MEDIATED INHIBITION OF FOS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 12/24/2003 | WO2003070182A3 Sodium channel blockers |
| 12/24/2003 | WO2003070153A3 Stabilized pharmaceutical compositions of halofuginone and other quinazolinone derivatives |
| 12/24/2003 | WO2003068760A3 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders |
| 12/24/2003 | WO2003066845A3 Bacteriophage lysin |
| 12/24/2003 | WO2003066840A3 Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
| 12/24/2003 | WO2003066806A3 Therapeutic use of aziridino compounds |
| 12/24/2003 | WO2003066048A3 Use of 15-lipoxygenase inhibitors for treating and preventing bone loss |
| 12/24/2003 | WO2003064685A3 Genetic polymorphisms in the preprotachykinin gene |
| 12/24/2003 | WO2003063800A3 8-heteroaryl xanthine adenosine a2b receptor antagonists |
| 12/24/2003 | WO2003053361A3 PYRROLOPYRIMIDINE A2b SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE |
| 12/24/2003 | WO2003047611A3 Ptp10d, tec and edtp involved in triglycerid-metabolism |
| 12/24/2003 | WO2003037362A3 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 12/24/2003 | WO2003032963A3 Method of reducing type 2 diabetes in high risk patients |
| 12/24/2003 | WO2003006491A3 Peptide-based compounds for targeting intergin receptors |
| 12/24/2003 | WO2002102997A3 Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 12/24/2003 | WO2002102990A8 Fibroblast growth factor and nucleic acid encoding same |
| 12/24/2003 | WO2002078644A8 Use of ozone for the treatment of dental and oral conditions |
| 12/24/2003 | WO2002058692A3 Halogenated composition, method for preparing same and uses thereof |
| 12/24/2003 | WO2002046147A3 Perturbed membrane-binding compounds |
| 12/24/2003 | WO2002038730A3 Novel human potassium channel beta subunit |
| 12/24/2003 | WO2002034204A8 Calcilytic compounds |
| 12/24/2003 | WO2002018540A3 Pyridine derivatives useful as cd40:cd154 binding interruptor compounds and use thereof to treat immunological complications |
| 12/24/2003 | WO2002010138A3 Uses of mammalian genes and related reagents |
| 12/24/2003 | WO2001085193A8 Method for promoting neovascularization using a tweak agonist and an angiogenic factor |
| 12/24/2003 | CN2593786Y Nano medicines against AIDS and hepatitis B |
| 12/24/2003 | CN1463191A Low hygroscopic aripiprazole drug substance and processes for prepn. thereof |
| 12/24/2003 | CN1462636A Vaccine of recombined albumen for preventing and treating infection of human C type hepatitis virus and its usage |
| 12/24/2003 | CN1462634A Method of producing tables of biology salcium with multienzyme |
| 12/24/2003 | CN1462633A Method of preparing mouth sprays dosage with multienzyme |